These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 31925319

  • 1. Natriuretic peptides in bronchopulmonary dysplasia: a systematic review.
    Xiong T, Kulkarni M, Gokulakrishnan G, Shivanna B, Pammi M.
    J Perinatol; 2020 Apr; 40(4):607-615. PubMed ID: 31925319
    [Abstract] [Full Text] [Related]

  • 2. N-terminal-probrain natriuretic peptide as a biomarker of moderate to severe bronchopulmonary dysplasia in preterm infants: A prospective observational study.
    Rodríguez-Blanco S, Oulego-Erroz I, Alonso-Quintela P, Terroba-Seara S, Jiménez-González A, Palau-Benavides M.
    Pediatr Pulmonol; 2018 Aug; 53(8):1073-1081. PubMed ID: 29790673
    [Abstract] [Full Text] [Related]

  • 3. N-Terminal Pro-B Type Natriuretic Peptide as a Marker of Bronchopulmonary Dysplasia or Death in Very Preterm Neonates: A Cohort Study.
    Sellmer A, Hjortdal VE, Bjerre JV, Schmidt MR, McNamara PJ, Bech BH, Henriksen TB.
    PLoS One; 2015 Aug; 10(10):e0140079. PubMed ID: 26452045
    [Abstract] [Full Text] [Related]

  • 4. Accuracy of brain natriuretic peptide and N-terminal brain natriuretic peptide for detecting paediatric pulmonary hypertension: a systematic review and meta-analysis.
    Zhou R, Lei Y, Ge L, Mao Q, Yang L, Qiu X.
    Ann Med; 2024 Dec; 56(1):2352603. PubMed ID: 38753384
    [Abstract] [Full Text] [Related]

  • 5. Brain natriuretic peptide and N-terminal brain natriuretic peptide for the diagnosis of haemodynamically significant patent ductus arteriosus in preterm neonates.
    Gokulakrishnan G, Kulkarni M, He S, Leeflang MM, Cabrera AG, Fernandes CJ, Pammi M.
    Cochrane Database Syst Rev; 2022 Dec 08; 12(12):CD013129. PubMed ID: 36478359
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Diagnosing significant PDA using natriuretic peptides in preterm neonates: a systematic review.
    Kulkarni M, Gokulakrishnan G, Price J, Fernandes CJ, Leeflang M, Pammi M.
    Pediatrics; 2015 Feb 08; 135(2):e510-25. PubMed ID: 25601976
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. B-type natriuretic peptide as a parameter for pulmonary hypertension in children. A systematic review.
    Ten Kate CA, Tibboel D, Kraemer US.
    Eur J Pediatr; 2015 Oct 08; 174(10):1267-75. PubMed ID: 26298682
    [Abstract] [Full Text] [Related]

  • 14. Brain Natriuretic Propeptide as an Early Marker of Bronchopulmonary Dysplasia or Death in the Preterm Newborn.
    Montaner A, Pinillos R, Galve Z, Boix H, de la Cuesta CR, Jimenez L, Samper P, Rite S.
    Klin Padiatr; 2017 Jul 08; 229(4):223-228. PubMed ID: 28718187
    [Abstract] [Full Text] [Related]

  • 15. Patent ductus arteriosus, systemic NT-proBNP concentrations and development of bronchopulmonary dysplasia in very preterm infants: retrospective data analysis from a randomized controlled trial.
    Potsiurko S, Dobryanskyy D, Sekretar L.
    BMC Pediatr; 2021 Jun 19; 21(1):286. PubMed ID: 34147090
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. B-type natriuretic peptide levels in preterm neonates with bronchopulmonary dysplasia: a marker of severity?
    Kalra VK, Aggarwal S, Arora P, Natarajan G.
    Pediatr Pulmonol; 2014 Nov 19; 49(11):1106-11. PubMed ID: 24214578
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Utility of B-type natriuretic peptides in the assessment of patients with systemic sclerosis-associated pulmonary hypertension in the PHAROS registry.
    Chung L, Fairchild RM, Furst DE, Li S, Alkassab F, Bolster MB, Csuka ME, Derk CT, Domsic RT, Fischer A, Frech TM, Gomberg-Maitland M, Gordon JK, Hinchcliff M, Hsu V, Hummers LK, Khanna D, Medsger TAJ, Molitor JA, Preston IR, Schiopu E, Shapiro L, Hant F, Silver R, Simms R, Varga J, Steen VD, Zamanian RT.
    Clin Exp Rheumatol; 2017 Nov 19; 35 Suppl 106(4):106-113. PubMed ID: 27908301
    [Abstract] [Full Text] [Related]

  • 20. [Diagnostic value of the currently used criteria and brain natriuretic peptide for diagnosing congestive heart failure in children with congenital heart disease].
    Wu YR, Chen SB, Sun K, Huang MR, Zhang YQ, Chen S.
    Zhonghua Er Ke Za Zhi; 2006 Oct 19; 44(10):728-32. PubMed ID: 17229370
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.